Dark

Check out our API

EIGR
Eiger BioPharmaceuticals, Inc.
stock NASDAQ

Inactive

Apr 10, 2024

1.73USD-9.211%(-0.18)137,824

Pre-market

0.00USD-100.000%(-1.90)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsTrends

EIGR Reddit Mentions

Subreddits

Limit Labels Price

We have sentiment values and mention counts going back to 2017. The complete data set is available via the API.

Take me to the API

EIGR Specific Mentions

As of Jul 2, 2026 1:33:15 AM EDT (1 min. ago)

Includes all comments and posts. Mentions per user per ticker capped at one per hour.

16 days ago • u/verdenc • r/biotech_stocks • can_anyone_name_any_recent_biotech_stock_success • C

This. AMLX had a negative EV due to a lead product blow up.
Them EIGR came along with it's upside down balance sheet and clinical fail and had to liquidate.
AMLX uses a fraction of its cash pile and spends $35MM to acquire avexitide program. After initiating phase 3, it trades up to $2b cap and settles in around $1.5 as it waits for a readout.
So yes, biotech wins do happen and AMLX is a great example. But like any position, knowing when to exit is the hardest part.

16 days ago • u/verdenc • r/biotech_stocks • can_anyone_name_any_recent_biotech_stock_success • C

This. AMLX had a negative EV due to a lead product blow up.
Them EIGR came along with it's upside down balance sheet and clinical fail and had to liquidate.
AMLX uses a fraction of its cash pile and spends $35MM to acquire avexitide program. After initiating phase 3, it trades up to $2b cap and settles in around $1.5 as it waits for a readout.
So yes, biotech wins do happen and AMLX is a great example. But like any position, knowing when to exit is the hardest part.

Share